Nikko Asset Management Americas, Inc. Ionis Pharmaceuticals Inc Transaction History
Nikko Asset Management Americas, Inc.
- $7.42 Billion
- Q1 2025
A detailed history of Nikko Asset Management Americas, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 142,433 shares of IONS stock, worth $5.91 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
142,433
Previous 156,657
9.08%
Holding current value
$5.91 Million
Previous $5.48 Million
21.53%
% of portfolio
0.06%
Previous 0.06%
Shares
25 transactions
Others Institutions Holding IONS
# of Institutions
398Shares Held
145MCall Options Held
916KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA16.4MShares$680 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$671 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$513 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$428 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$349 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.89B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...